What are the new cholesterol guidelines 2020?
What are the new cholesterol guidelines 2020?
The new guidelines advocate a multifaceted approach to primary prevention of atherosclerotic cardiovascular disease through cholesterol management….Adults age 40–75, without diabetes, with LDL-C levels 70–189 mg/dL
- Low risk: < 5%
- Borderline risk: 5%–7.5%
- Intermediate risk: 7.5%–20%
- High risk: > 20%.
How many statin treatment groups are there?
Four groups of patients are recommended for intense statin treatment: Adults with clinical ASCVD, which encompasses coronary artery disease, peripheral artery disease, transient ischemic attack or stroke. Adults age 40 to 75 with diabetes. Adults of any age with LDL above 190.
Was the juice worth the squeeze Understanding the New 2018 AHA ACC cholesterol guideline?
In the case of the updated cholesterol guidelines, we do believe the juice was worth the squeeze. Start with guideline-directed statin intensity and increase up to maximally tolerated statin dosing if not achieving expected LDL-C reduction goal (≥50% for high-intensity, 30-50% moderate intensity).
When should a statin patient be started?
This guideline states “In adults 40 to 75 years of age without diabetes mellitus and with LDL-C levels ≥70 mg/dL (≥1.8mmol/L), at a 10-year atherosclerotic cardiovascular disease risk of ≥7.5 percent, start a moderate-intensity statin if a discussion of treatment options favors statin therapy.”
When is statin recommended?
The U.S. Preventive Services Task Force recommends low- to moderate-dose statins in adults ages 40 to 75 who have one or more risk factors for heart and blood vessel disease and at least a 1 in 10 chance of having a cardiosvascular disease event in the next 10 years.
What’s the ACC guideline for high intensity statin therapy?
An algorithm for determining appropriate statin therapy for patients who are candidates for treatment is presented in eFigure A. Specific classes of recommendation, levels of evidence, and their definitions are available in the full guideline. Table 2. Age ≤ 75 years and no safety concerns: high-intensity statin (COE = I; LOE = A)
How many groups of patients can benefit from statin therapy?
Individual responses may vary ACC/AHA recommendations: According to the ACC/AHA, there are 4 groups of patients that could benefit from statin therapy, of moderate or high intensity.1
When to consider non-statin drugs for ASCVD?
After attention to lifestyle changes and statin therapy, non-statin drugs may be considered if you have high-risk with known ASCVD, diabetes, or very high LDL cholesterol values (≥190 mg/dL) and: Have side effects from statins that prevent you from getting to the optimal dose or are not able to take a statin at all.
What was the purpose of the ACC 2018 cholesterol guideline?
Writing Committee: The purpose of the present guideline is to address the practical management of patients with high blood cholesterol and related disorders. The 2018 Cholesterol Guideline is a full revision of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterolto Reduce Atherosclerotic Cardiovascular Risk in Adults.